Plunkett Research Online: Mylan NV

MYLAN NV (MYL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Mylan N.V. develops, licenses, manufactures, distributes and markets generic/branded pharmaceutical products, specialty pharmaceuticals and active pharmaceutical ingredients (APIs). The firm offers one of the industry’s broadest product portfolios, including more than 7,500 marketed products around.....



Mylan NV
Ticker: MYL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 44 01707853000
Fax: 44 01707261803
Address: Building 4, Trident Place
Mosquito Way
Hatfield, Herts AL10 9UL United Kingdom

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Generic
Generic Pharmaceuticals
Active Pharmaceutical Ingredients
ContactsDescription
Heather BreschCEO/Director
Kenneth ParksCFO
See More
Mylan N.V. develops, licenses, manufactures, distributes and markets generic/branded pharmaceutical products, specialty pharmaceuticals and active pharmaceutical ingredients (APIs). The firm offers one of the industry’s broadest product portfolios, including more than 7,500 marketed products around.....See More See More

Auditor: Deloitte & Touche LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
EipPen
Perforomist
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: